{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T21:03:44Z","timestamp":1778360624798,"version":"3.51.4"},"reference-count":51,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"vor","delay-in-days":1461,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1038\/ki.2013.213","type":"journal-article","created":{"date-parts":[[2013,10,9]],"date-time":"2013-10-09T12:38:15Z","timestamp":1381322295000},"page":"1145-1153","source":"Crossref","is-referenced-by-count":61,"title":["Phosphate restriction significantly reduces mortality in uremic rats with established vascular calcification"],"prefix":"10.1016","volume":"84","author":[{"given":"Jane L.","family":"Finch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duk H.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Liapis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindy","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edu","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leon","family":"Ferder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Slatopolsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2013.213_bb0010","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","article-title":"Clinical epidemiology of cardiovascular disease in chronic renal disease","volume":"32","author":"Foley","year":"1988","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2013.213_bb0015","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/ndt\/gfg414","article-title":"Arterial media calcification in end stage renal disease: impact on all cause and cardiovascular mortality","volume":"18","author":"London","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2013.213_bb0020","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1053\/j.ajkd.2003.12.005","article-title":"Vascular calcification in kidney disease","volume":"43","author":"Goodman","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2013.213_bb0025","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium \u00d7 phosphate product with mortality risk in chronic hemodialysis patients: a national study","volume":"31","author":"Block","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2013.213_bb0030","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0272-6386(00)70064-3","article-title":"Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management","volume":"35","author":"Block","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2013.213_bb0035","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1046\/j.1523-1755.63.s85.26.x","article-title":"Higher impact of mineral metabolism on cardiovascular mortality in a European hemodialysis population","volume":"85","author":"Marco","year":"2003","journal-title":"Kidney Int Suppl"},{"key":"10.1038\/ki.2013.213_bb0040","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1053\/j.ajkd.2005.08.013","article-title":"The Kidney Disease Outcomes Quality Initiative (K\/DOQI) guideline for bone metabolism and disease in CKD: association with mortality in dialysis patients","volume":"46","author":"Noordzij","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2013.213_bb0045","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000190244","article-title":"Vascular calcification in long-term haemodialysis patients in a single unit: a retrospective analysis","volume":"77","author":"Goldsmith","year":"1997","journal-title":"Nephron"},{"key":"10.1038\/ki.2013.213_bb0050","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/ndt\/15.7.1014","article-title":"Arterial stiffening and vascular calcifications in end-stage renal disease","volume":"15","author":"Guerin","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2013.213_bb0055","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1161\/01.CIR.100.21.2168","article-title":"Medial localization of mineralization-regulating proteins in association with M\u00f6nckeberg\u2019s sclerosis: evidence for smooth muscle cell\u2013mediated vascular calcification","volume":"100","author":"Shanahan","year":"1999","journal-title":"Circulation"},{"key":"10.1038\/ki.2013.213_bb0060","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1172\/JCI117246","article-title":"High expression of genes for calcification-regulating proteins in human atherosclerotic plaques","volume":"93","author":"Shanahan","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2013.213_bb0065","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1210\/jc.2003-031432","article-title":"Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-kappaB ligand in Monckeberg\u2019s sclerosis and atherosclerosis","volume":"89","author":"Schoppet","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/ki.2013.213_bb0070","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0021-9150(83)90163-6","article-title":"The identification of the vitamin K-dependent bone protein osteocalcin as one of the gamma-carboxyglutamic acid containing proteins present in calcified atherosclerotic plaque and mineralized heart valves","volume":"46","author":"Levy","year":"1983","journal-title":"Atherosclerosis"},{"key":"10.1038\/ki.2013.213_bb0075","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0092-8674(00)80259-7","article-title":"Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development","volume":"89","author":"Otto","year":"1997","journal-title":"Cell"},{"key":"10.1038\/ki.2013.213_bb0080","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/jcb.10369","article-title":"Regulation of the osteoblast-specific transcription factor, Runx2: responsiveness to multiple signal transduction pathways","volume":"88","author":"Franceschi","year":"2003","journal-title":"J Cell Biochem"},{"key":"10.1038\/ki.2013.213_bb0085","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/01.RES.0000161997.24797.c0","article-title":"Regulation of vascular calcification: roles of phosphate and osteopontin","volume":"96","author":"Giachelli","year":"2005","journal-title":"Circ Res"},{"key":"10.1038\/ki.2013.213_bb0090","doi-asserted-by":"crossref","first-page":"20197","DOI":"10.1074\/jbc.M909174199","article-title":"Phosphorylation of osteopontin is required for inhibition of vascular smooth muscle cell calcification","volume":"275","author":"Jono","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1038\/ki.2013.213_bb0095","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1161\/hh2401.101070","article-title":"Smooth muscle cell phenotypic transition associated with calcification: up regulation of Cbfa 1 and down regulation of smooth muscle lineage markers","volume":"89","author":"Steitz","year":"2001","journal-title":"Circ Res"},{"key":"10.1038\/ki.2013.213_bb0100","first-page":"556","article-title":"Impact of calcium, phosphate, PTH abnormalities and management on mortality in hemodialysis: results from the RISCAVID study","volume":"23","author":"Panichi","year":"2010","journal-title":"J Nephrol"},{"key":"10.1038\/ki.2013.213_bb0105","first-page":"381","article-title":"Simultaneous lowering of serum phosphate and LDL-cholesterol by sevelamer hydrochloride (Rena Gel) in dialysis patients","volume":"50","author":"Wilkes","year":"1998","journal-title":"Clin Nephrol"},{"key":"10.1038\/ki.2013.213_bb0110","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","article-title":"Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients","volume":"62","author":"Chertow","year":"2002","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2013.213_bb0115","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/j.1523-1755.2005.00600.x","article-title":"Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis","volume":"68","author":"Block","year":"2002","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2013.213_bb0120","first-page":"134","article-title":"Valvular calcification in hemodialysis patients randomized to calcium-based phosphorus binders or sevelamer","volume":"13","author":"Raggi","year":"2004","journal-title":"J Heart Valve Dis"},{"key":"10.1038\/ki.2013.213_bb0125","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.ahj.2004.07.023","article-title":"Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients","volume":"149","author":"Ferramosca","year":"2005","journal-title":"Am Heart J"},{"key":"10.1038\/ki.2013.213_bb0130","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1081\/JDI-65259","article-title":"Effect of sevelamer on dyslipidemia and chronic inflammation in maintenance hemodialysis patients","volume":"27","author":"Yamada","year":"2005","journal-title":"Ren Fail"},{"key":"10.1038\/ki.2013.213_bb0135","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000111061","article-title":"Effects of sevelamer and calcium-based phosphate binders on lipid and inflammatory markers in hemodialysis patients","volume":"28","author":"Shantouf","year":"2008","journal-title":"Am J Nephrol"},{"key":"10.1038\/ki.2013.213_bb0140","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2215\/CJN.02810707","article-title":"Short-term treatment with sevelamer increases serum fetuin-a concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients","volume":"3","author":"Caglar","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.213_bb0145","doi-asserted-by":"crossref","first-page":"F1376","DOI":"10.1152\/ajprenal.90737.2008","article-title":"The calcimimetic AMG 641 accelerates regression of extraosseous calcification in uremic rats","volume":"296","author":"Lopez","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/ki.2013.213_bb0150","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1097\/01.ASN.0000095248.91994.D3","article-title":"Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats","volume":"14","author":"Adamczac","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.213_bb0155","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1161\/01.HYP.0000149249.09147.b4","article-title":"Role of podocytes for reversal of glomerulosclerosis and proteinuria in the aging kidney after endothelin inhibition","volume":"44","author":"Ortmann","year":"2004","journal-title":"Hypertension"},{"key":"10.1038\/ki.2013.213_bb0160","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJM197801192980302","article-title":"Preservation of function in experimental renal disease by dietary restriction of phosphate","volume":"298","author":"Ibels","year":"1978","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2013.213_bb0165","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/ki.1989.281","article-title":"Phosphate excess and progressive renal failure: the precipitation-calcification hypothesis","volume":"36","author":"Lau","year":"1989","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2013.213_bb0170","first-page":"15","article-title":"Role of phosphate retention in the progression of renal failure","volume":"122","author":"Loghmen-Adham","year":"1993","journal-title":"J Lab Clin Med"},{"key":"10.1038\/ki.2013.213_bb0175","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1046\/j.1523-1755.2003.00284.x","article-title":"Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia","volume":"64","author":"Cozzolino","year":"2003","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2013.213_bb0180","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1093\/ndt\/gfg309","article-title":"Sevelamer hydrochloride, a phosphate binder, protects against deterioration of renal function in rats with progressive chronic renal insufficiency","volume":"18","author":"Nagano","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2013.213_bb0185","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1053\/j.ajkd.2010.10.055","article-title":"Effect of sevelamer and calcium-based phosphate binders on coronary artery calcification and accumulation of circulating advanced glycation end products in hemodialysis patients","volume":"57","author":"Kakuta","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2013.213_bb0190","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/sj.ki.5002518","article-title":"The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer","volume":"72","author":"Russo","year":"2007","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2013.213_bb0195","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1093\/ndt\/14.12.2907","article-title":"Long-term effects of sevelamer hydrochloride on the calcium \u00d7 phosphate product and lipid profile of haemodialysis patients","volume":"14","author":"Chertow","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2013.213_bb0200","doi-asserted-by":"crossref","first-page":"934","DOI":"10.2215\/CJN.12891211","article-title":"Effects of sevelamer on Hba1c, inflammation, and advanced glycation end products in diabetic kidney disease","volume":"7","author":"Vlassara","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.213_bb0205","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/MNH.0b013e328338f536","article-title":"Recent advances in the rapidly evolving field of fibroblast growth factor 23 in chronic kidney disease","volume":"19","author":"Zisman","year":"2010","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1038\/ki.2013.213_bb0210","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1007\/s00198-011-1838-0","article-title":"FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages","volume":"23","author":"Desjardins","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1038\/ki.2013.213_bb0215","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/ki.2012.176","article-title":"Update on fibroblast growth factor 23 in chronic kidney disease","volume":"82","author":"Wolf","year":"2012","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2013.213_bb0220","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1053\/j.ajkd.2011.11.007","article-title":"Comparison of calcium acetate and sevelamer on vascular function and fibroblast growth factor 23 in CKD patients: a randomized clinical trial","volume":"59","author":"Yilmaz","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2013.213_bb0225","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1053\/ajkd.2001.24533","article-title":"Calciphylaxis is associated with hyperphosphatemia and increased osteopontin expression by vascular smooth muscle cells","volume":"37","author":"Ahmed","year":"2001","journal-title":"Kidney Dis"},{"key":"10.1038\/ki.2013.213_bb0230","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1096\/fasebj.7.15.8262332","article-title":"Osteopontin: a protein with diverse functions","volume":"7","author":"Denhardt","year":"1993","journal-title":"FASEB J"},{"key":"10.1038\/ki.2013.213_bb0235","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/01.RES.84.2.166","article-title":"Calcification of vascular smooth muscle cell cultures. Inhibition by osteopontin","volume":"84","author":"Wada","year":"1999","journal-title":"Circ Res"},{"key":"10.1038\/ki.2013.213_bb0240","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1046\/j.1523-1755.2003.00864.x","article-title":"Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia","volume":"63","author":"Aman","year":"2003","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2013.213_bb0245","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/heartjnl-2011-300570","article-title":"Serum phosphate is associated with left ventricular mass in patients with chronic kidney disease: a cardiac magnetic resonance study","volume":"98","author":"Chue","year":"2012","journal-title":"Heart"},{"key":"10.1038\/ki.2013.213_bb0250","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1001\/jama.292.19.2350","article-title":"Prognostic significance of left ventricular mass change during treatment of hypertension","volume":"292","author":"Devereux","year":"2004","journal-title":"JAMA"},{"key":"10.1038\/ki.2013.213_bb0255","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.ki.5002406","article-title":"Differential effects of vitamin D receptor activators on vascular calcification in uremic rats","volume":"72","author":"Mizobuchi","year":"2007","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2013.213_bb0260","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1681\/ASN.2006091028","article-title":"Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats","volume":"18","author":"Mizobuchi","year":"2007","journal-title":"J Am Soc Nephrol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815561048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815561048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T09:23:04Z","timestamp":1539336184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815561048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0085253815561048"],"URL":"https:\/\/doi.org\/10.1038\/ki.2013.213","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}